VEGFA and neoplasm: In combination with bevacizumab, a vascular endothelial growth factor (VEGF)-A antibody, anti-GD2 CAR T cells were massively infiltrated into the tumor mass to inhibit tumor growth in an orthotopic xenograft mouse model [217].